A Two-Year Longitudinal Study of Persistent Lean Tissue Deficits in Children With Crohn's Disease

Clinical Gastroenterology and Hepatology

Volumn 7, Issue 4, 2009, Pages 452-455

  Sylvester, Francisco A ^a   Leopold, Scott ^b   Lincoln, Miriam ^a   Hyams, Jeffrey S ^a   Griffiths, Anne M ^c   Lerer, Trudy ^a  

^a UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE   (United States)

^b Department of Obstetrics Gynecology   (United States)

^c HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

INFLIXIMAB; INTERLEUKIN 6; MERCAPTOPURINE; PREDNISONE; SOMATOMEDIN C;

ADOLESCENT; AGE; ARTICLE; BODY COMPOSITION; BODY HEIGHT; BODY MASS; BODY WEIGHT; BONE MINERAL; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CROHN DISEASE; DISEASE ACTIVITY; DRUG DOSE REDUCTION; ENTERITIS; FAT FREE MASS; FEMALE; HUMAN; LONGITUDINAL STUDY; MALE; PRESCHOOL CHILD; SCHOOL CHILD; SEXUAL MATURATION;

ADOLESCENT; BODY COMPOSITION; BODY MASS INDEX; BONE DENSITY; CHILD; CROHN DISEASE; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; THINNESS;

EID: 62849084123     PISSN: 15423565     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cgh.2008.12.017     Document Type: Article

References (26)

1. Hyams J.S. Inflammatory bowel disease. Pediatr Rev 26 (2005) 314-320
2. Kirschner B.S., and Sutton M.M. Somatomedin-C levels in growth-impaired children and adolescents with chronic inflammatory bowel disease. Gastroenterology 91 (1986) 830-836
3. Griffiths A.M., Nguyen P., Smith C., et al. Growth and clinical course of children with Crohn's disease. Gut 34 (1993) 939-943
4. Kirschner B.S. Permanent growth failure in pediatric inflammatory bowel disease. J Pediatr Gastroenterol Nutr 16 (1993) 368-369
5. Tjellesen L., Nielsen P.K., and Staun M. Body composition by dual-energy X-ray absorptiometry in patients with Crohn's disease. Scand J Gastroenterol 33 (1998) 956-960
6. Jahnsen J., Falch J.A., Mowinckel P., et al. Body composition in patients with inflammatory bowel disease: a population-based study. Am J Gastroenterol 98 (2003) 1556-1562
7. Haderslev K.V., Jeppesen P.B., Sorensen H.A., et al. Body composition measured by dual-energy X-ray absorptiometry in patients who have undergone small-intestinal resection. Am J Clin Nutr 78 (2003) 78-83
8. Burnham J.M., Shults J., Semeao E., et al. Whole body BMC in pediatric Crohn disease: independent effects of altered growth, maturation, and body composition. J Bone Miner Res 19 (2004) 1961-1968
9. Burnham J.M., Shults J., Semeao E., et al. Body-composition alterations consistent with cachexia in children and young adults with Crohn disease. Am J Clin Nutr 82 (2005) 413-420
10. Thayu M., Shults J., Burnham J.M., et al. Gender differences in body composition deficits at diagnosis in children and adolescents with Crohn's disease. Inflamm Bowel Dis 13 (2007) 1121-1128
11. Bernstein C.N., and Leslie W.D. Therapy insight: osteoporosis in inflammatory bowel disease-advances and retreats. Nat Clin Pract Gastroenterol Hepatol 2 (2005) 232-239
12. Frost H.M. Bone "mass" and the "mechanostat": a proposal. Anat Rec 219 (1987) 1-9
13. Sylvester F.A., Davis P.M., Wyzga N., et al. Are activated T cells regulators of bone metabolism in children with Crohn disease?. J Pediatr 148 (2006) 461-466
14. Sylvester F.A., Wyzga N., Hyams J.S., et al. Natural history of bone metabolism and bone mineral density in children with inflammatory bowel disease. Inflamm Bowel Dis 13 (2007) 42-50
15. Hyams J.S., Ferry G.D., Mandel F.S., et al. Development and validation of a pediatric Crohn's disease activity index. J Pediatr Gastroenterol Nutr 12 (1991) 439-447
16. Greulich W.W., and Pyle S.I. Radiographic atlas of skeletal development of the hand and wrist. 2nd ed. (1959), Stanford University Press, Stanford, CA
17. van der Sluis I.M., de Ridder M.A., Boot A.M., et al. Reference data for bone density and body composition measured with dual energy x ray absorptiometry in white children and young adults. Arch Dis Child 87 (2002) 341-347
18. Ellis K.J., Shypailo R.J., Abrams S.A., et al. The reference child and adolescent models of body composition: a contemporary comparison. Ann N Y Acad Sci 904 (2000) 374-382
19. Chandran R., Knobloch T.J., Anghelina M., et al. Biomechanical signals upregulate myogenic gene induction in the presence or absence of inflammation. Am J Physiol Cell Physiol 293 (2007) C267-C276
20. Dogra C., Changotra H., Mohan S., et al. Tumor necrosis factor-like weak inducer of apoptosis inhibits skeletal myogenesis through sustained activation of nuclear factor-kappaB and degradation of MyoD protein. J Biol Chem 281 (2006) 10327-10336
21. Dehoux M., Gobier C., Lause P., et al. IGF-I does not prevent myotube atrophy caused by proinflammatory cytokines despite activation of Akt/Foxo and GSK-3beta pathways and inhibition of atrogin-1 mRNA. Am J Physiol Endocrinol Metab 292 (2007) E145-E150
22. Beaufrere B., Horber F.F., Schwenk W.F., et al. Glucocorticosteroids increase leucine oxidation and impair leucine balance in humans. Am J Physiol 257 Pt 1 (1989) E712-E721
23. Schoenau E., Neu C.M., Beck B., et al. Bone mineral content per muscle cross-sectional area as an index of the functional muscle-bone unit. J Bone Miner Res 17 (2002) 1095-1101
24. Varghese S., Wyzga N., Griffiths A.M., et al. Effects of serum from children with newly diagnosed Crohn disease on primary cultures of rat osteoblasts. J Pediatr Gastroenterol Nutr 35 (2002) 641-648
25. Sylvester F.A., Wyzga N., Hyams J.S., et al. Effect of Crohn's disease on bone metabolism in vitro: a role for interleukin-6. J Bone Miner Res 17 (2002) 695-702
26. Azcue M., Rashid M., Griffiths A., et al. Energy expenditure and body composition in children with Crohn's disease: effect of enteral nutrition and treatment with prednisolone. Gut 41 (1997) 203-208